Welcome to the international HTA database

Showing [23731 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2010	Institute of Health Economics (IHE)	Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
1997	NIHR Health Technology Assessment programme	Routine preoperative testing: a systematic review of the evidence
2007	Institute of Health Economics (IHE)	Routine preoperative tests - are they necessary?
2000	NIHR Health Technology Assessment programme	Routine referral for radiography of patients presenting with low back pain: is patients' outcome influenced by GPs' referral for plain radiography?
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Routine replacement of peripheral intravenous catheters
1999	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Routine skull x-rays in head injury
2010	HAYES, Inc.	Routine ultrasound examination in low-risk pregnancy
1996	British Columbia Office of Health Technology Assessment (BCOHTA)	Routine ultrasound imaging in pregnancy: how evidence-based are the guidelines?
1998	The Swedish Council on Health Technology Assessment (SBU)	Routine ultrasound in pregnancy
2004	Quality Improvement Scotland (NHS QIS )	Routine ultrasound scanning before 24 weeks of pregnancy; HTA Advice 5: Routine ultrasound scanning before 24 weeks of pregnancy; Understanding our Advice: Routine ultrasound scanning before 24 weeks of pregnancy
2003	Agency for Healthcare Research and Quality (AHRQ)	Routine vitamin supplementation to prevent cancer
2003	Agency for Healthcare Research and Quality (AHRQ)	Routine vitamin supplementation to prevent cardiovascular disease
2014	HAYES, Inc.	Roux-en-Y gastric bypass for diabetes in obese or severely obese patients
2013	HAYES, Inc.	Roux-en-Y gastric bypass for gastroesophageal reflux disease in obese or severely obese patients
2017	HAYES, Inc.	Roux-en-Y gastric bypass for treatment of Type II Diabetes: a review of reviews
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	ROX Coupler for treatment-resistant hypertension
2022	National Institute for Health and Care Excellence (NICE)	Roxadustat for treating symptomatic anaemia in chronic kidney disease. NICE technology appraisal guidance 807
2003	NIHR Horizon Scanning Centre (NIHR HSC)	Rubitecan resistant refractory pancreatic cancer - horizon scanning review
2003	NIHR Horizon Scanning Centre (NIHR HSC)	Ruboxistaurin for diabetic neuropathy - horizon scanning review
2006	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ruboxistaurin mesylate hydrate
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Rucaparib for advanced BRCA-mutated ovarian cancer
2024	National Institute for Health and Care Excellence (NICE)	Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. NICE technology appraisal guidance 1007
2019	National Institute for Health and Care Excellence (NICE)	Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. NICE technology appraisal guidance 611
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Rufinamide (Inovelon®) 40 mg/ml oral suspension
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Rufinamide (Inovelon®) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS)
2000	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Ruptured intracranial aneurysm: endovascular occlusion versus microsurgical clipping
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ruxolitinib (Jakavi) for polycythaemia vera – second line
2010	NIHR Horizon Scanning Centre (NIHR HSC)	Ruxolitinib for myelofibrosis - first line
2012	NIHR Health Technology Assessment programme	Ruxolitinib for the treatment of myelofibrosis
2022	National Institute for Health and Care Excellence (NICE)	Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids (terminated appraisal). NICE technology appraisal guidance 839
2022	National Institute for Health and Care Excellence (NICE)	Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal). NICE technology appraisal guidance 840
2016	National Institute for Health and Care Excellence (NICE)	Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis. NICE technology appraisal guidance 386
2022	Agency for Care Effectiveness (ACE)	Ruxolitinib for treating polycythaemia vera
2023	National Institute for Health and Care Excellence (NICE)	Ruxolitinib for treating polycythaemia vera. NICE technology appraisal guidance 921
2012	HAYES, Inc.	Ryanodine receptor 1 (RYR1) testing for malignant hyperthermia susceptibility (MHS)
2008	NIHR Horizon Scanning Centre (NIHR HSC)	S-1 for advanced gastric cancer - first line therapy
2002	Agency for Healthcare Research and Quality (AHRQ)	S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease
2013	HAYES, Inc.	S-ICD (Subcutaneous Implantable Cardioverter Defibrillator; Boston Scientific Corp.) for prevention of sudden cardiac death
2022	National Institute for Health and Care Excellence (NICE)	Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies. NICE technology appraisal guidance 819
2002	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Sacral nerve stimulation device for urinary incontinence
2005	Medical Services Advisory Committee (MSAC)	Sacral nerve stimulation for faecal incontinence
2004	National Institute for Health and Care Excellence (NICE)	Sacral nerve stimulation for faecal incontinence. NICE interventional procedures guidance 99
2015	National Institute for Health and Care Excellence (NICE)	Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention. NICE interventional procedures guidance 536
2000	Medical Services Advisory Committee (MSAC)	Sacral nerve stimulation for refractory urinary urge incontinence or urinary retention
2004	National Institute for Health and Care Excellence (NICE)	Sacral nerve stimulation for urge incontinence and urgency-frequency. NICE interventional procedures guidance 64
2008	Medical Services Advisory Committee (MSAC)	Sacral nerve stimulation for urinary indications
2005	Medical Advisory Secretariat (MAS)	Sacral nerve stimulation for urinary urge incontinence, urgency-frequency, urinary retention, and fecal incontinence: an evidence-based analysis
2007	Centre Hospitalier de l'Universite de Montreal(CHUM)	Sacral nerve stimulation in fecal incontinence
2018	Health Technology Wales (HTW)	Sacral nerve stimulation to treat faecal incontinence that cannot be controlled with conservative management
2021	NIHR Health Technology Assessment programme	Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCT
2017	National Institute for Health and Care Excellence (NICE)	Sacrocolpopexy using mesh to repair vaginal vault prolapse. NICE interventional procedures guidance 583
2017	National Institute for Health and Care Excellence (NICE)	Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse. NICE interventional procedures guidance 577
2012	HAYES, Inc.	Sacroiliac joint fusion for the treatment of adult low back pain
2008	HAYES, Inc.	Sacroiliac joint fusion for the treatment of adult low back pain
2011	HAYES, Inc.	Sacroiliac joint fusion for treatment of adult low back pain
2014	Andalusian Health Technology Assessment Area (AETSA)	Sacroiliac joint fusion. Open versus minimally invasive surgery.
2014	HAYES, Inc.	Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain
2016	HAYES, Inc.	Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain
2008	HAYES, Inc.	Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain
2004	NIHR Horizon Scanning Centre (NIHR HSC)	Sacrosidase (Sucraid) for congenital sucrase-isomaltase deficiency - horizon scanning review
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Sacubitril in combination with valsartan for chronic heart failure
2016	National Institute for Health and Care Excellence (NICE)	Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction. NICE technology appraisal guidance 388
2016	HAYES, Inc.	Sacubitril-valsartan (Entresto) for heart failure
2022	Agency for Care Effectiveness (ACE)	Sacubitril/valsartan for treating chronic heart failure with reduced ejection fraction
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Safe surgery during the coronavirus disease 2019 crisis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	SafePlace for the peripheral insertion of central venous catheters in infants
2024	NIHR Health Services and Delivery Research programme	Safer and more efficient vital signs monitoring protocols to identify the deteriorating patients in the general hospital ward: an observational study
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Safety and effectiveness of outpatient compared with inpatient induction of labour in singleton uncomplicated pregnancies
2016	Andalusian Health Technology Assessment Area (AETSA)	Safety and effectiveness of perfusion machine in solid organ transplantation
2011	Penn Medicine Center for Evidence-based Practice (CEP)	Safety and effectiveness of rhBMP-2 (infuse bone graft) for spinal fusion: 2011 update
2003	Institute for Clinical Effectiveness and Health Policy (IECS)	Safety and efficacy of cochlear implants
2007	Institute of Health Economics (IHE)	Safety and efficacy of inhaled nitric oxide in the management of hypoxemic respiratory failure in adults with acute respiratory distress syndrome
2002	Centre for Clinical Effectiveness (CCE)	Safety and efficacy of percutaneous vertebroplasty in symptomatic osteoporotic vertebral compression fractures
2007	Quality Improvement Scotland (NHS QIS )	Safety and risk associated with free standing midwife led maternity units (MLMU)
2012	Scottish Health Technologies Group (SHTG)	Safety and risk associated with free standing midwife led maternity units. This evidence note updates evidence note 18 published in August 2007
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Safety of air vents in psychiatric units in a hospital setting: a review of the clinical evidence and guidelines
1999	Health Council of the Netherlands Gezondheidsraad (GR)	Safety of amino acid supplementation
2022	NIHR Health Services and Delivery Research programme	Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations
1992	Health Council of the Netherlands Gezondheidsraad (GR)	Safety of food produced by new biotechnology
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Safety of leflunomide and methotrexate as combination therapy for rheumatoid arthritis: a review of the clinical evidence
2011	Agency for Healthcare Research and Quality (AHRQ)	Safety of probiotics used to reduce risk and prevent or treat disease
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Safety of renal biopsy for patients taking aspirin
2014	Agency for Healthcare Research and Quality (AHRQ)	Safety of vaccines used for routine immunization in the United States
2021	Agency for Healthcare Research and Quality (AHRQ)	Safety of vaccines used for routine immunization in the United States: an update
2020	Norwegian Institute of Public Health (NIPH)	Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2003	Andalusian Health Technology Assessment Area (AETSA)	Safety, efficacy and efficiency of transmyocardial laser. Update of evidence-Systematic Review.
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Safinamide for early stage Parkinson's disease - adjuvant therapy
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Safinamide for mid-to-late stage Parkinson's disease - adjuvant therapy
2015	NIHR Health Technology Assessment programme	Saline in Acute Bronchiolitis RCT and Economic evaluation: hypertonic saline in acute bronchiolitis - randomised controlled trial and systematic review
1999	Medical Services Advisory Committee (MSAC)	Saline infusion sonohysterography
2005	HAYES, Inc.	Salivary estriol test for preterm labor
2013	HAYES, Inc.	Salivary hormone testing for menopausal women
2000	Health Council of the Netherlands Gezondheidsraad (GR)	Salt intake and hypertension
1999	Medical Services Advisory Committee (MSAC)	Samarium-153-lexidronam for bone pain due to skeletal metastases
2022	WorkSafeBC	SANUWAVE therapy for wound healing
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Sapacitabine - acute myeloid leukaemia: patients ≥70 years of age; not candidates for standard intensive therapy – first line
2006	NIHR Horizon Scanning Centre (NIHR HSC)	Sapropterin dihydrochloride for phenylketonuria: horizon scanning technology briefing
2021	National Institute for Health and Care Excellence (NICE)	Sapropterin for treating hyperphenylalaninaemia in phenylketonuria. NICE technology appraisal guidance 729
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SAR-302503 for myelofibrosis – first line
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SAR236553/REGN727 for the reduction of elevated total cholesterol and low density lipoprotein cholesterol